This contract expires in 207 days (Jan 4, 2027).

Browse related active opportunities

FIRM FIXED PRICESMALL BUSINESS SET ASIDE - TOTAL

CHARTWELL RX LLC - DOXYCYCLINE HYCLATE 100 MG ORAL TABLETS

PIID: 75A50325F80009
Signed Date: Dec 12, 2025Effective Date: Jun 23, 2025End Date: Closes in 207 days
Award $
$98.7M
Vendor
CHARTWELL RX LLC
NAICS
325412
Signed Date
Dec 12, 2025

Key Details

Dollars Obligated
$98.7M
Base & All Options
Awarding Sub-Agency
Office of Assistant Secretary for Preparedness and Response
Product Service Code
6505 - DRUGS AND BIOLOGICALS
Extent Competed
FULL AND OPEN COMPETITION
Number of Offers
2
Place of Performance
CONGERS, NY, 109200001, CD-NY-17

Description

DOXYCYCLINE HYCLATE 100 MG ORAL TABLETS

Context & Analysis

On Dec 12, 2025, Department of Health and Human Services obligated $98,684,252.16 to CHARTWELL RX LLC for doxycycline hyclate 100 mg oral tablets. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 2 offers received. The procurement used a SMALL BUSINESS SET ASIDE - TOTAL set-aside. Performance is located in CONGERS, NY. The contract is scheduled through Jan 4, 2027 — approximately 7 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 325412 — related awards are listed below.

Contractor Information

Contractor: CHARTWELL RX LLC
UEI: ER5UA9TYBGH4
CAGE Code: 8APG0
Location: CONGERS, NY
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related